TY - JOUR
AU - K. Noam
AU - C. Bory
AU - E. Flanagan
AU - J. Wigglesworth
AU - R. Plant
A1 - 
AD - Carelon Behavioral Health Connecticut, 500 Enterprise Drive, Suite 3D, Rocky Hill, CT, 06067, USA; Yale Program for Recovery and Community Health, 319 Peck Street Building 1, New Haven, CT, 06513, USA.; Carelon Behavioral Health Connecticut, 500 Enterprise Drive, Suite 3D, Rocky Hill, CT, 06067, USA.; Yale Program for Recovery and Community Health, 319 Peck Street Building 1, New Haven, CT, 06513, USA. Electronic address: elizabeth.flanagan@yale.edu.
AN - 40359803
BT - J Psychiatr Res
C5 - Healthcare Disparities
DA - Apr 15
DO - 10.1016/j.jpsychires.2025.04.023
DP - NLM
ET - 20250415
JF - J Psychiatr Res
LA - eng
PY - 2025
SN - 0022-3956
SP - 108
EP - 115+
ST - Predictors of Metabolic Syndrome (MetS) and the benefits of using the MetS diagnosis for people with serious and persistent mental illness
T1 - Predictors of Metabolic Syndrome (MetS) and the benefits of using the MetS diagnosis for people with serious and persistent mental illness
T2 - J Psychiatr Res
TI - Predictors of Metabolic Syndrome (MetS) and the benefits of using the MetS diagnosis for people with serious and persistent mental illness
U1 - Healthcare Disparities
U3 - 10.1016/j.jpsychires.2025.04.023
VL - 187
VO - 0022-3956
Y1 - 2025
ER -